Latest news
Nippon Primex 1Q Net Y142.00M Vs Net Y40.00M - MoomooMoomoo · Fri, 07 Aug 2026 06:00:00 GMTNippon Care Supply Co 1Q Net Y545.00M Vs Net Y464.00M - MoomooMoomoo · Thu, 06 Aug 2026 05:32:24 GMTAB2 Bio receives USD 30 million from Nippon Shinyaku - Greater Geneva Bern area (GGBa)Greater Geneva Bern area (GGBa) · Mon, 03 Aug 2026 12:07:14 GMTAB2 Bio Receives $30 Million From Nippon Shinyaku For U.S. Tadekinig Alfa Rights, With Up To $600 Million In Milestones And Royalties - Pulse 2.0Pulse 2.0 · Mon, 03 Aug 2026 01:58:58 GMTAB2 Bio gets $30M from Nippon Shinyaku for U.S. rights to Tadekinig alfa treating rare hyperinflammatory syndrome - PluangPluang · Thu, 30 Jul 2026 07:19:23 GMTAB2 Bio Gets $30 Mln From Nippon Shinyaku For U.S. Rights To Tadekinig Alfa - TradingViewTradingView · Thu, 30 Jul 2026 06:51:00 GMTAB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 06:37:58 GMT